However, in breast cancer cell lines examined after docetaxel treatment, exposure to CRT was observed, and the killing ability of CTLs was enhanced by the increased components of the antigen-processing system and membrane translocation of CRT [59]. This evidence concerns the gene CALR and breast carcinoma.